Literature DB >> 4627962

Long-term preservation and storage of mycobacteria.

T H Kim, G P Kubica.   

Abstract

Under contract with the National Institute of Allergy and Infectious Diseases, the Trudeau Mycobacterial Culture Collection has been greatly expanded to provide for the scientific community a collection of representative strains of mycobacteria of biomedical importance. Problems concerned with the preparation, bottling, and distribution of such organisms have been dealt with and are detailed in this paper. Examination of collected data revealed that the temperature of storage and not the suspending menstruum was more important for prolonged survival of mycobacteria stored at subzero temperatures. For optimum results, mycobacteria may be suspended either in Dubos Tween-albumin broth or in Middlebrook 7H-9 liquid medium supplemented with ADC enrichment (commercial sources used) and stored at -70 C. Either of these suspending fluids supplied a growth-supporting medium for cultures which must be shipped long distances, often without refrigeration. To avoid sublimation of suspending medium during prolonged storage at -70 C (a problem inherent in many screw-capped containers), we have chosen to use vaccine-stoppered serum bottles sealed with aluminum crimp caps. The methods described have provided suspensions with (i) excellent viability over prolonged periods of storage, (ii) stable metabolic activities, and (iii) highly reproducible inocula for animal experiments.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4627962      PMCID: PMC376516          DOI: 10.1128/am.24.3.311-317.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  8 in total

1.  Laboratory suggestion: simple method for maintaining stock cultures of Mycobacterium species.

Authors:  W D JONES
Journal:  Am J Clin Pathol       Date:  1957-03       Impact factor: 2.493

2.  Freeze-dried B.C.G. vaccine; methods adopted in preparation of a standard product.

Authors:  P FARMER; P W MUGGLETON; J UNGAR
Journal:  Br Med J       Date:  1956-09-08

3.  The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. I. Homogeneity of the investigation and a critique of the virulence test.

Authors:  D A MITCHISON; A L BHATIA; S RADHAKRISHNA; J B SELKON; T V SUBBAIAH; J G WALLACE
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

4.  A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis.

Authors:  F M Collins; G B Mackaness; V Montalbine; M M Smith
Journal:  Am Rev Respir Dis       Date:  1968-08

5.  Mycobacterium intracellulare. Maintenance of pathogenicity in relationship to lyophilization and colony form.

Authors:  F P Dunbar; I Pejovic; R Cacciatore; L Peric-Golia; E H Runyon
Journal:  Scand J Respir Dis       Date:  1968

6.  Preservation of mycobacterial cultures.

Authors:  H Gruft; M E Clark; M Osterhout
Journal:  Appl Microbiol       Date:  1968-02

7.  A co-operative numerical anaysis of scotochromogenic slowly growing mycobacteria.

Authors:  L G Wayne; T M Dietz; C Gernez-Rieux; P A Jenkins; W Käppler; G P Kubica; J B Kwapinski; G Meissner; S R Pattyn; E H Runyon; K H Schröder; V A Silcox; A Tacquet; M Tsukamura; E Wolinsky
Journal:  J Gen Microbiol       Date:  1971-06

8.  Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70 C.

Authors:  A A Grover; H K Kim; E H Wiegeshaus; D W Smith
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

  8 in total
  21 in total

1.  Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.

Authors:  Mary A De Groote; Veronica Gruppo; Lisa K Woolhiser; Ian M Orme; Janet C Gilliland; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Preservation of mycobacteria: 100 percent viability of suspensions stored at -70 C.

Authors:  T H Kim; G P Kubica
Journal:  Appl Microbiol       Date:  1973-06

3.  Growth of mycobacterium bovis (BCG) in T lymphocyte-depleted mice.

Authors:  F M Collins; C C Congdon; N E Morrison
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

4.  Preservation of mycobacteria st -70 degrees C: persistence of key differential features.

Authors:  G P Kubica; P P Gontijo-Filho; T Kim
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

5.  Experience with low temperature storage of bacteria and fungi.

Authors:  H J Kessler; U Redmann
Journal:  Infection       Date:  1974       Impact factor: 3.553

6.  Cryopreservation of Mycobacterium tuberculosis complex cells.

Authors:  Zhiquan Shu; Kris M Weigel; Scott D Soelberg; Annie Lakey; Gerard A Cangelosi; Kyong-Hoon Lee; Jae-Hyun Chung; Dayong Gao
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

7.  Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas.

Authors:  Scott M Irwin; Veronica Gruppo; Elizabeth Brooks; Janet Gilliland; Michael Scherman; Matthew J Reichlen; Rachel Leistikow; Igor Kramnik; Eric L Nuermberger; Martin I Voskuil; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

8.  Relative immunogenicity of streptomycin-sensitive and -resistant strains of BCG.

Authors:  F M Collins; V Montalbine
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

9.  Response of hypersensitive mice to the footpad injection of living homologous or heterologous mycobacteria: preliminary report.

Authors:  G P Kubica; F P Dunbar; T H Kim
Journal:  Appl Microbiol       Date:  1973-05

10.  High-viability lyophilized Bacille Calmette-Guérin vaccine produced by deep-culture technique.

Authors:  T H Kim
Journal:  Appl Environ Microbiol       Date:  1977-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.